Corvus Pharmaceuticals Inc buy BiotechBee
Start price
08.09.24
/
50%
€3.72
Target price
31.08.27
€5.00
Performance (%)
88.71%
End price
14.12.24
€7.02
Summary
This prediction ended on 14.12.24 with a price of €7.02. The BUY prediction by BiotechBee for Corvus Pharmaceuticals Inc saw massive gains of 88.71%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -6.470% | -6.470% | -23.475% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
According to BiotechBee what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Buy mit Kursziel 5,0
In the thread Trading Corvus Pharmaceuticals Inc
Buy beendet

